Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice

Biochemical Pharmacology

Volumn 63, Issue 10, 2002, Pages 1893-1900

  Yang, Qian ^a   Xie, Yi ^a   Alexson, Stefan E H ^b   Dean Nelson, B ^a   DePierre, Joseph W ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Immunomodulation; Lymphocyte; Mice; Peroxisome proliferator; PPAR ; Spleen; Splenocyte; Thymocyte; Thymus

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL POPULATION; CONTROLLED STUDY; DRUG EFFECT; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LIPID BLOOD LEVEL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REDUCTION; RODENT; SPLEEN; SPLEEN CELL; SPLEEN WEIGHT; T LYMPHOCYTE; THYMOCYTE; THYMUS; WILD TYPE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; FLUOROCARBONS; LIVER; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MODELS, ANIMAL; OCTANOIC ACIDS; ORGAN SIZE; PEROXISOME PROLIFERATORS; PEROXISOMES; PYRIMIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SPLEEN; THYMUS GLAND; TRANSCRIPTION FACTORS;

EID: 0037094349     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)00923-1     Document Type: Article

References (39)

1. Peroxisome proliferation: Current mechanisms relating to nongenotoxic carcinogenesis
2. Peroxisome proliferators: Mechanisms of adverse effects in rodents and molecular basis for species differences
3. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators
4. Immunotoxicity of pesticides: A review
5. Chemical agents and the immune response
6. Effects of peroxisome proliferators on the thymus and spleen of mice
7. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluorooctanoic acid in mice
8. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid
9. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
10. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
11. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
12. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
13. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643
14. Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice
15. The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids
16. Disposition of perfluorodecanoic acid in male and female rats
17. Perfluorooctanoic acid has persistent effects on peroxisome proliferation and related parameters in mouse liver
18. Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay
19. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
20. + T cells in a responder strain
21. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)
22. Rat PPARs: Quantitative analysis in adult rat tissues and regulation in fasting and refeeding
23. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase: A potential mechanism for the hypolipidemic action of fibrates
24. Promotion of human T lymphocyte activation and proliferation by fatty acids in low density and high density lipoproteins
25. Human T lymphocytes require lipid as either lipoprotein or nonesterified fatty acid for in vitro activation
26. Lipoproteins may provide fatty acids necessary for human lymphocyte proliferation by both low density lipoprotein receptor-dependent and -independent mechanisms
27. Metabolism in lymphocytes and its importance in the immune response
28. The role of cholesterol and its biosynthesis in lymphocyte proliferation and differentiation
29. Membrane compartmentation and the response to antigen
30. The caveolae membrane system
31. Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation
32. Transcriptional control of triglyceride metabolism: Fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR
33. Perfluorooctanoic acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decreases secretion of very low density lipoproteins by cultured rat hepatocytes
34. The PPARalpha-leukotriene B4 pathway to inflammation control
35. Effect of peroxisome proliferator-activated receptor alpha activation on leukotriene B(4) metabolism in isolated rat hepatocytes
36. Cell-mediated immunity in atherosclerosis
37. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein